| Authors | Spero R Cataland, Flora Peyvandi, Pier M Mannucci, Bernhard Lämmle, Johanna A Kremer Hovinga, Samuel J Machin, Marie Scully, Gail Rock, James C Gilbert, Shangbin Yang, Haifeng Wu, Bernd Jilma, Paul Knoebl |
| Journal | American journal of hematology
(Am J Hematol)
Vol. 87
Issue 4
Pg. 430-2
(Apr 2012)
ISSN: 1096-8652 [Electronic] United States |
| PMID | 22367751
(Publication Type: Letter, Multicenter Study, Randomized Controlled Trial)
|
| Chemical References |
- ARC 1779
- Aptamers, Nucleotide
- Immunosuppressive Agents
- von Willebrand Factor
- ADAM Proteins
- ADAMTS13 Protein
- ADAMTS13 protein, human
|
| Topics |
- ADAM Proteins
(blood)
- ADAMTS13 Protein
- Adult
- Aptamers, Nucleotide
(administration & dosage, adverse effects, therapeutic use)
- Catheter-Related Infections
(etiology)
- Combined Modality Therapy
- Consciousness Disorders
(etiology)
- Double-Blind Method
- Early Termination of Clinical Trials
- Epilepsy
(etiology)
- Female
- Humans
- Immunosuppressive Agents
(therapeutic use)
- Infusions, Intravenous
(adverse effects)
- Male
- Middle Aged
- Plasma Exchange
- Platelet Count
- Protein Binding
(drug effects)
- Protein Structure, Tertiary
- Purpura, Thrombotic Thrombocytopenic
(complications, drug therapy, physiopathology, therapy)
- von Willebrand Factor
(antagonists & inhibitors, physiology)
|
